Specify Company / Ticker to Get the Summary
Artrya Ltd
AYAArtrya Limited, a medical technology company, engages in the development and commercialisation of artificial intelligence platform that detects, diagnoses, and address coronary artery disease in Australia. The company offers Salix, a cloud-based software that uses its AI to automate the detection of coronary artery disease from coronary computed tomography angiography scans which identifies and manages patients at risk of a heart attack. Artrya Limited was incorporated in 2018 and is based in West Perth, Australia. Address: 1257 Hay Street, West Perth, WA, Australia, 6005
Analytics
WallStreet Target Price
3.76 AUDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures AYA
Dividend Analytics AYA
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History AYA
Stock Valuation AYA
Financials AYA
Results | 2019 | Dynamics |